News

Published on 28 Feb 2024 on Zacks via Yahoo Finance

Intellia Therapeutics, Inc. (NTLA) Crossed Above the 50-Day Moving Average: What That Means for...


Article preview image

Intellia Therapeutics, Inc. (NTLA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, NTLA broke through the 50-day moving average, which suggests a short-term bullish trend.

One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down trend.

Shares of NTLA have been moving higher over the past four weeks, up 26.2%. Plus, the company is currently a Zacks Rank #2 (Buy) stock, suggesting that NTLA could be poised for a continued surge.

NASDAQ.NTLA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?

We expect investors to focus on Intellia Therapeutics, Inc.’s NTLA progress with the development ...

Zacks via Yahoo Finance 25 Apr 2024

Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline

Intellia Therapeutics, Inc. (NTLA) is expected to deliver a year-over-year decline in earnings on...

Zacks via Yahoo Finance 25 Apr 2024

Intellia Therapeutics (NASDAQ:NTLA shareholders incur further losses as stock declines 9.9% this...

Investing in stocks inevitably means buying into some companies that perform poorly. But the long...

Simply Wall St. via Yahoo Finance 6 Apr 2024

Intellia Therapeutics, Inc. (NTLA) Crossed Above the 50-Day Moving Average: What That Means for...

Intellia Therapeutics, Inc. (NTLA) reached a significant support level, and could be a good pick ...

Zacks via Yahoo Finance 28 Feb 2024

Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing...

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocur...

Benzinga 26 Feb 2024

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Analysts Are Cutting Their Estimates: Here's What You Need...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) shareholders are probably feeling a little disappointed...

Simply Wall St. via Yahoo Finance 25 Feb 2024

Wall Street Analysts See an 185.54% Upside in Intellia Therapeutics, Inc. (NTLA): Can the Stock...

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 8.3% over the past four weeks to close t...

Zacks via Yahoo Finance 23 Feb 2024

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript February 22, 2024 Inte...

Insider Monkey via Yahoo Finance 23 Feb 2024

Earnings call: Intellia outlines robust clinical pipeline and financial health By Investing.com

Intellia Therapeutics (ticker: NASDAQ:NTLA) has reported a productive fourth quarter and full yea...

Investing.com 22 Feb 2024

Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More

We are in the last leg of the fourth-quarter 2023 reporting cycle and a lot of pharma and biotech...

Zacks via Yahoo Finance 21 Feb 2024